PRA Health Sciences Late Phase Services is participating in a global real world safety study program, mandated by various regulatory bodies, to confirm risk/benefit profile for a novel oral anticoagulant to assess the drug’s bleeding risk. Our ability to provide global operational oversight and efficiencies, ensure consistent communication with sites, and keep our patients engaged resulted in PRA becoming the client’s CRO of choice.
Explore related content and topics
Webinar
THE INSIGHT SERIES: Do Late Phase Studies Offer Any Scientific Value? – Part 2
The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these…
View Resource
Blog
Advocacy Groups in Patient-Focused Drug Development
Read Story
Webinar
THE INSIGHT SERIES: Is there any way to expedite the start-up processes for global non-interventional research? - Part 5
When new drugs are approved, the marketing authorization holders often have to commit themselves to perform additional post-authorization studies.…
View Resource
View all related content and resources for Real World Solutions
Explore Insights